Outcome of treatment for distal bile duct cancer

@article{Fong1996OutcomeOT,
  title={Outcome of treatment for distal bile duct cancer},
  author={Yuman Fong and Leslie H. Blumgart and E. Lin and Joseph G. Fortner and Murray F. Brennan},
  journal={British Journal of Surgery},
  year={1996},
  volume={83}
}
All patients with distal bile duct tumours over a 10‐year period (October 1983 to December 1993) were identified by means of a prospective database. The medical records of 104 patients were reviewed. Univariate and multivariate analysis for predictors of outcome was performed. Median age of the patients was 65 (range 30–89) years. Patients presented with a clinical picture indistinguishable from that of pancreatic ductal adenocarcinoma. Twenty patients had no surgical treatment and 23 had a… 

Clinical Presentation, Diagnosis and Survival of Resected Distal Bile Duct Cancer

The aim of the study was the definition of the clinical features and survival of 27 resected cases of distal bile duct carcinoma. This neoplasm accounted for 14% of all periampullary malignancies

Prognostic factors in patients with middle and distal bile duct cancers.

PD had a greater likelihood of curative resection and R1 resection might have some positive impact, and the TNM stage and LVI were independent prognostic factors.

Distal Bile Duct Carcinoma: Prognostic Factors After Curative Surgery. A Series of 112 Cases

Overexpression of p53 in DBDC is strongly associated with significantly reduced survival, independently of clinicopathological prognostic factors, and longer operative time may have unfavorable effect on prognosis of patients with DBDC.

Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.

Five-year survival depends strongly on negative resection margins, independent of nodal status, and portal vein resections in patients with portal vein involvement fail to ameliorate long-term survival.

Prognostic Factors after Pancreatoduodenectomy for Distal Bile Duct Cancer

Lymph node involvement was the most important survival predictor after a Whipple resection in patients with distal cholangiocarcinoma and was shown to be an independent prognostic factor of survival.

Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions.

It is suggested that patients with resected proximal and distal cholangiocarcinoma will experience similar operative outcomes and DSS.

Prognostic factors following surgical resection of distal bile duct cancer

R0 resection is the most important so that frozen sections should be utilized aggressively during each operation, and further study on postoperative adjuvant treatment may be warranted.

Survival predictors of patients with primary duodenal adenocarcinoma.

The resectability of primary duodenal adenocarcinoma was associated with a smaller tumor size, a lower degree of tumor depth invasiveness, and less spread to the lymph nodes and distant organs.

A Clinicopathological Study of Distal Bile Duct Carcinoma at Fukuyama Medical Center

Log-rank analysis revealed that pathological pancreatic and duodenal invasion and curative resectability may be prognostic factors, while lymph node metastasis and perineural and stump invasion did not affect prognosis.
...

References

SHOWING 1-10 OF 17 REFERENCES

Prognostic Factors in Bile Duct Carcinoma: Analysis of 96 Cases

A computerized analysis of prognostic variables was performed in 96 proven cases of extrahepatic bile duct carcinoma treated over a 24-year period at IJCI, finding thatection of these difficult carcinomas offers the best hope of survival but must be weighed against the high operative mortality risk in those lesions located in the hilar region.

Results of surgical treatment of periampullary tumors: a thirty-five-year experience.

The data justify continued use of a selective radical approach in the resection of most periampullary tumors with local resection for small tumors in high-risk patients.

Outcomes after curative resections of cholangiocarcinoma.

Although the tumor extent and the patient's overall health will affect outcome, curative resection for cholangiocarcinoma at all sites should be undertaken since this treatment offers the best chance for long-term survival.

Surgical treatment of cancer of the pancreas and the periampullary region: cumulative results in 57 institutions in Japan.

In this study the experiences with carcinomas of the pancreas, ampulla of Vater, terminal comma bile duct, and duodenum found in a series of 3,610 patients collected from 57 major Japanese

Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy.

Data from 1972 patients who had undergone pancreaticoduodenectomy or total pancreatectomy for malignancy in New York State between 1984 and 1991 support a defined minimum hospital experience for elective pancreatic resection for maligne to minimize perioperative deaths.

Survival After Pancreatoduodenectomy: 118 Consecutive Resections Without an Operative Mortality

The present analysis of the last 118 consecutive pancreatoduodenectomies performed at the Surgical University Clinic Mannheim from November 1985 to the present day with no deaths finds general agreement on operative technique, but there were differences concerning preoperative evaluation and postoperative care.

Surgical Experience with Pancreatic and Periampullary Cancer

It is concluded that survival after resection for ductal pancreatic cancer is so rare as to be considered more a biologic aberration than a result of radical surgery.

One hundred and forty-five consecutive pancreaticoduodenectomies without mortality.

With appropriate preoperative selection, virtually any patient in any age group, with benign or malignant disease, can undergo pancreaticoduodenectomy with minimal risk of hospital mortality.